Delivery Order SPE2DB24D2205-SPE2DB25FDUJK

Award Date 11/19/24
Potential Completion Date 11/20/24
Potential Value $1.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DB24D2205
    Indefinite Delivery Contract
  • SPE2DB24D2205-SPE2DB25FDUJK
    Delivery Order

This federal contract award is for the pharmaceutical product AIMOVIG 140 MG/ML AUTOINJECTORML, awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract has a firm fixed price of $1,357.86 and a completion date of November 20, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor registered in the System for Award Management (SAM.gov) since 2002. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This latest award is likely a delivery order against that larger IDC contract.

Generated 2/18/25, 1:39 PM